MME stands for morphine milligram equivalents. It’s a standardized unit used to compare the strength of different opioid pain medications by converting each one to an equivalent dose of morphine. If you’ve seen this abbreviation on a prescription label, in a medical record, or in a news article about opioid safety, it’s referring to this measurement system.
Why MME Exists
Not all opioid medications are equally potent. A 10 mg tablet of one opioid might deliver very different pain relief than a 10 mg tablet of another. That makes it difficult to compare doses across different drugs or to track how much total opioid a person is actually taking, especially if they’re prescribed more than one type.
MME solves this by translating every opioid dose into how many milligrams of morphine would produce the same effect. Morphine is simply the reference point, the common language. A provider can look at a patient’s total daily MME and immediately understand the overall opioid exposure, regardless of which specific medications are involved. This is useful for tracking changes in a patient’s opioid use over time, identifying tolerance, comparing opioid use across large groups in research, and flagging doses that may carry higher safety risks.
You may also see MME written as OME (oral morphine equivalents) or MEDD (morphine equivalent daily dose). They all describe the same concept.
How MME Is Calculated
The basic calculation multiplies the dose of an opioid by a conversion factor specific to that drug. Each opioid has its own factor based on how potent it is relative to morphine. For example, a drug twice as strong as morphine has a conversion factor of 2, so 10 mg of that drug equals 20 MME.
When someone takes more than one opioid, the MME for each medication is calculated separately, then added together to get a total daily MME. This combined number is what providers and guidelines focus on, because the risk of side effects and overdose depends on total opioid exposure from all sources, not just one prescription.
The 50 MME Threshold
The CDC’s 2022 Clinical Practice Guideline for Prescribing Opioids identifies 50 MME per day as a key safety threshold. Once a patient’s combined opioid dose from all sources reaches or exceeds 50 MME per day, the guideline recommends additional precautions: more frequent follow-up visits, overdose prevention education, and a prescription for naloxone (a medication that can reverse an opioid overdose) for the patient and their household.
The reasoning is straightforward. Doses above 50 MME per day are unlikely to provide meaningfully better pain control for most people, while overdose risk climbs substantially. Each increase beyond that point tends to yield diminishing returns in pain relief relative to growing danger.
The numbers bear this out. In studies of chronic pain patients, daily doses between 50 and 99 MME were associated with roughly 2 to 5 times the risk of overdose compared to doses under 20 MME. At 100 MME per day or higher, the risk jumped to 2 to 9 times greater. For acute pain, the pattern is similar: doses of 50 to 99 MME per day carried about 4.7 times the overdose risk, and doses at or above 100 MME carried about 6.6 times the risk, compared to doses under 20 MME per day.
Even relatively low doses in the range of 20 to 50 MME per day are associated with increased risk, according to the CDC. There is no perfectly “safe” opioid dose, but risk rises in a dose-dependent way.
Why MME Is an Estimate, Not an Exact Science
MME is a useful tool, but it has real limitations. The conversion factors are approximations. They don’t account for individual differences in how people metabolize drugs, which can vary significantly based on genetics. They also don’t account for something called incomplete cross-tolerance, which means that someone who has built up tolerance to one opioid won’t necessarily tolerate an equivalent dose of a different opioid.
This is why MME works well as a population-level safety metric and a general clinical guide, but it doesn’t replace individualized judgment about a specific patient. Two people at the same daily MME can have very different responses, side effects, and risk profiles depending on their biology, other medications, and medical history.
Where You Might Encounter MME
If you’re a patient taking prescription opioids, you may see MME referenced in pharmacy printouts, insurance documentation, or during conversations with your provider. Many states now have laws requiring pharmacies or prescribers to flag prescriptions that exceed certain MME thresholds, often 50 or 90 MME per day. Some insurance plans use MME limits to determine when prior authorization is required before filling a prescription.
In public health reporting and news coverage of the opioid crisis, MME appears frequently as a way to quantify prescribing trends. A statement like “average MME per capita declined by 30%” is describing an overall reduction in the strength and volume of opioids prescribed to a population, translated into that common morphine-based unit.